Hims & Hers Health, Inc. revenue
Hims & Hers Health, Inc.'s revenue was $2.35bn in fiscal 2025, up 59.0% on the year before. Since fiscal 2019 ($82.6m) it has grown at a compound 74.7% a year. Over the last twelve months it was $2.58bn.
Revenue history
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 83 | 149 | 272 | 527 | 872 | 1,477 | 2,348 | 2,578 |
| Growth on the year before | — | +80.2% | +82.8% | +93.8% | +65.5% | +69.3% | +59.0% | — |
| Gross profit | 45 | 109 | 204 | 409 | 715 | 1,173 | 1,733 | 1,764 |
| Gross margin | 54.0% | 73.6% | 75.2% | 77.6% | 82.0% | 79.5% | 73.8% | 68.4% |
Where the revenue comes from
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $2.2B | 94.3% | ▲ 52.7% |
| Outside the US | $134M | 5.7% | ▲ 399.2% |
From Hims & Hers Health, Inc.'s 10-K filed February 23, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Hims & Hers Health, Inc. | $2.58bn | 28.0% | 53.7% |
| Aveanna Healthcare Holdings, Inc. | $2.60bn | 19.5% | 12.4% |
| Chemed Corp | $2.66bn | 5.2% | 6.1% |
| Privia Health Group, Inc. | $2.36bn | 24.1% | 16.1% |
| Radnet, Inc. | $2.27bn | 18.9% | 14.1% |
| Evolent Health, Inc. | $2.10bn | -4.5% | 8.7% |
Compare with peers
- Aveanna Healthcare Holdings, Inc. revenue
- Chemed Corp revenue
- Privia Health Group, Inc. revenue
- Radnet, Inc. revenue
- Evolent Health, Inc. revenue
Head to head: AVAH vs HIMSCHE vs HIMSHIMS vs PRVAHIMS vs RDNT
More: Health Care Services stocks compared, Health Care sector, rankings of US companies